arrow
S

Sean C. Elias

University of Oxford
H指数:29
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The age-specific concentrations and seroprevalence of antibodies against Salmonella Enteritidis (O:9) and Salmonella Typhimurium (O:4,5) across three sites in Kenya.

肯尼亚三个地点的年龄特异性浓度以及针对Salmonella Enteritidis (O:9)和Salmonella Typhimurium (O:4,5)抗体的血清流行率。

2026-03-040
OA
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial

ChAd63/MVA Pfs25-IMX313在第一阶段人体试验中的安全性和免疫原性

2021-07-1426
OAAI
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

布基纳法索儿童季节性接种低剂量候选疟疾疫苗R21和佐剂matrix-m的疗效: 一项随机对照试验

LANCET
IF88.5
2021-05-01270
OAAI
Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors
2021-03-0132
OAAI
The Severe Typhoid Fever in Africa Program: Study Design and Methodology to Assess Disease Severity, Host Immunity, and Carriage Associated With Invasive Salmonellosis

非洲严重伤寒发热计划: 评估疾病严重程度,宿主免疫力以及与侵袭性沙门氏菌病相关的运输的研究设计和方法

2019-10-3020
OAAI
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans
2019-04-0163
OAAI
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions
2017-11-0264
OA
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies
2017-06-15103
OA
Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria Infection
2016-10-1314
OAAI
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01
2016-02-0483
OAAI
Preclinical assessment of viral vectored and protein vaccines targeting the Duffy-binding protein region II of Plasmodium vivax

针对间日疟原虫Duffy结合蛋白区域II的病毒载体和蛋白疫苗的临床前评估

2015-07-0839
OAAI
Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection
2014-12-1285
OAAI
Combining Viral Vectored and Protein-in-adjuvant Vaccines Against the Blood-stage Malaria Antigen AMA1: Report on a Phase 1a Clinical Trial
2014-12-0156
OAAI
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
2013-11-28252
OAAI